Nixon Peabody Trust’s Elevance Health ELV Stock Holding History

Nixon Peabody Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.21M	Buy	23,817 +319	+1%	+$118K	0.65%	48
2026 Q1	$6.88M	Buy	23,498 +1,608	+7%	+$528K	0.55%	53
2025 Q4	$7.67M	Sell	21,890 -172	-0.8%	-$58.1K	0.58%	49
2025 Q3	$7.13M	Buy	22,062 +161	+0.7%	+$50.1K	0.52%	54
2025 Q2	$8.52M	Buy	21,901 +96	+0.4%	+$38.6K	0.66%	48
2025 Q1	$9.48M	Buy	21,805 +9,846	+82%	+$3.95M	0.81%	43
2024 Q4	$4.41M	Buy	+11,959	New	+$5M	0.36%	54

Other funds holding ELV

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MIHAS

Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Nixon Peabody Trust's ELV Position: Q2 2026 in Review

Nixon Peabody Trust increased its Elevance Health (ELV) stake by 1.4% in Q2 2026, buying an estimated $118K and bringing the position to 23,817 shares worth $9.21M. The position accounts for 0.65% of the portfolio, ranked #48.

Nixon Peabody Trust first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.48M in Q1 2025. 513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Nixon Peabody Trust held 23,817 shares of Elevance Health worth $9.21M as of Q2 2026.
Nixon Peabody Trust bought 319 Elevance Health shares in Q2 2026, an estimated $118K.
Elevance Health made up 0.65% of Nixon Peabody Trust's portfolio in Q2 2026, its #48 holding.
Nixon Peabody Trust first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
Nixon Peabody Trust's Elevance Health position peaked at $9.48M in Q1 2025.
513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.